Investment opportunities in the medical industry

HKD 5.4 billion! 30% premium for privatization!

Securities Times · Jun 25 11:20

Investment in expanding production has seen initial results! The supply shortage of Eli Lilly and Co in Japan has been alleviated, and the shipping control has been finally lifted.

Zhitong Finance · Jun 6 13:33

Did the big reversal cause the stock price to skyrocket? Kangfang Biotech's “head-to-head” efficacy is better than K medicine. Industry: bullets need to fly a little longer

cls.cn · May 31 17:54

Bad raid! This pharmaceutical stock once plummeted 58%!

券商中國 · May 29 14:21

There were two fires in a week! Novo Nordisk says diet drug production capacity has not been affected

cls.cn · May 22 23:05

The 40-1 ratio is huge! The new version of the US House of Representatives “Biosafety Act” was passed in a hearing. The industry suggests paying attention to the subsequent run-in between the two house versions of the bill

cls.cn · May 16 11:15

Beijing has brought great benefits to innovative drugs!

券商中國 · Apr 8 15:52

MSD's major new drug for pulmonary hypertension was approved, priced at $14,000 per bottle

cls.cn · Mar 27 20:52

“Weight loss elixir” can cure kidney disease. Why is Novo Nordisk's stock price not rising but falling?

cls.cn · Mar 6 08:53

As diet pills continue to be “hot and hot,” Goldman Sachs boldly predicts that it will increase US GDP by 1% in the next few years!

Zhitong Finance · Feb 23 08:21

More than just “weight loss elixir” analysts are optimistic that Eli Lilly's market capitalization will hit 1 trillion US dollars

cls.cn · Feb 18 15:25

Who wouldn't want to be the next Jia Ling? Supply is in short supply, and the expansion of production of the “Weight Loss Duo” is progressing smoothly

wallstreetcn · Feb 11 17:16

Hong Kong Stock Concept Tracking | Pharmaceutical companies' pricing is being loosened? The innovative drug sector is expected to usher in a beta market (with concept stocks)

Zhitong Finance · Feb 7 08:35

The number of new drugs approved by the US FDA jumped 50% last year. Can biomedical concept stocks continue to benefit?

cls.cn · Jan 3 18:23

Piper Sandler Announces 2024 Biotech Stock Preferred List!

Golden10 Data · Dec 29, 2023 22:21

AstraZeneca acquires Chinese cancer drug developer with a deal value of about US$1.2 billion

cls.cn · Dec 26, 2023 19:42

Eli Lilly's tilpotide is expected to become the strongest “weight loss drug”. Agency: Expected sales volume to reach 27 billion US dollars in 2029

Zhitong Finance · Dec 25, 2023 18:44

Hamena broke a new high in the reversal market. How did the US health insurance giant, 25 times larger in 25 years, get through the economic bulls and bears?

Column · Sep 21, 2022 16:36

Cell and gene therapy CDMO is expected to become a tenfold investment circuit in the next ten years

專欄 · Jul 9, 2021 17:46

The market is buzzing about the new anti-tumor drug regulations. What does this mean for the booming CXO industry?

華爾街見聞 · Jul 5, 2021 07:31

Investment strategy for the second half of 2021: sector mining, close to the main “consumption+innovation” investment line

專欄 · Jun 30, 2021 16:58

The arrival of the COVID-19 vaccine is a big plus! The Moderna vaccine produced antibodies to the “Delta” strain, and the stock price soared to a record high

Bloomberg · Jun 30, 2021 08:22

570 billion vaccine giants are frantically expanding production. What are the signs? The epidemic revealed two major differences in expectations. Has the vaccine pattern changed?

券商中國 · Jun 23, 2021 09:21

The sector has collectively skyrocketed! Announcement on the national procurement plan for artificial joints, favoring leading domestic producers

富途資訊 · Jun 22, 2021 09:46